SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Holmberg Erik) "

Sökning: WFRF:(Holmberg Erik)

  • Resultat 11-20 av 467
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
11.
  • Edberg, Niklas J. T., et al. (författare)
  • Effects of Saturn's magnetospheric dynamics on Titan's ionosphere
  • 2015
  • Ingår i: Journal of Geophysical Research - Space Physics. - 2169-9380 .- 2169-9402. ; 120:10, s. 8884-8898
  • Tidskriftsartikel (refereegranskat)abstract
    • We use the Cassini Radio and Plasma Wave Science/Langmuir probe measurements of the electron density from the first 110 flybys of Titan to study how Saturn's magnetosphere influences Titan's ionosphere. The data is first corrected for biased sampling due to varying solar zenith angle and solar energy flux (solar cycle effects). We then present results showing that the electron density in Titan's ionosphere, in the altitude range 1600-2400km, is increased by about a factor of 2.5 when Titan is located on the nightside of Saturn (Saturn local time (SLT) 21-03h) compared to when on the dayside (SLT 09-15 h). For lower altitudes (1100-1600km) the main dividing factor for the ionospheric density is the ambient magnetospheric conditions. When Titan is located in the magnetospheric current sheet, the electron density in Titan's ionosphere is about a factor of 1.4 higher compared to when Titan is located in the magnetospheric lobes. The factor of 1.4 increase in between sheet and lobe flybys is interpreted as an effect of increased particle impact ionization from approximate to 200eV sheet electrons. The factor of 2.5 increase in electron density between flybys on Saturn's nightside and dayside is suggested to be an effect of the pressure balance between thermal plus magnetic pressure in Titan's ionosphere against the dynamic pressure and energetic particle pressure in Saturn's magnetosphere.
  •  
12.
  • Fernström, Erik, et al. (författare)
  • Results of preoperative chemoradiotherapy for patients with advanced cancer of the nasal cavity and paranasal sinuses.
  • 2017
  • Ingår i: Acta oto-laryngologica. - : Informa UK Limited. - 1651-2251 .- 0001-6489. ; 137:12, s. 1292-1300
  • Tidskriftsartikel (refereegranskat)abstract
    • Curative treatment of nasal cavity and paranasal sinus cancer is challenging due to the proximity to critical anatomical structures. The purpose of this study was to analyze the impact of trimodality therapy with preoperative chemotherapy and reduced-dose radiotherapy followed by organ-preserving surgery for treating patients with nasal cavity and paranasal sinus cancer.This retrospective study included all 156 patients diagnosed with sinonasal cancer in western Sweden between 1986 and 2009. We determined the treatment selection pattern and treatment outcomes for 79 patients treated with preoperative chemoradiotherapy.Squamous cell carcinoma was the most common histology. The five-year overall survival was 54%, and 85% of these patients had T3 or T4 tumors. The five-year cumulative incidence rate of local recurrence was 32%. The five-year overall survival in patients with squamous cell carcinoma and adenocarcinoma was 45% and 76%, respectively. The median preoperative radiation dose was 48Gy. Orbital exenteration was performed in 7% of patients.Preoperative chemoradiotherapy may be beneficial for patients with advanced sinonasal cancer when primary radical surgery is challenging. Survival outcomes were comparable to outcomes reported in the literature despite conservative surgery and relatively low radiation doses in patients with locally advanced tumors.
  •  
13.
  • Frykholm, Erik, 1985-, et al. (författare)
  • Applicability of a supramaximal high-intensity interval training program for older adults previously not engaged in regular exercise : analyses of secondary outcomes from the Umeå HIT Study
  • 2024
  • Ingår i: Psychology of Sport And Exercise. - : Elsevier. - 1469-0292 .- 1878-5476. ; 73
  • Tidskriftsartikel (refereegranskat)abstract
    • This analysis of secondary outcomes investigated the applicability of supramaximal high-intensity interval training (HIT) with individually prescribed external intensity performed on stationary bicycles. Sixty-eight participants with a median (min; max) age of 69 (66; 79), at the time not engaged in regular exercise were randomized to 25 twice-weekly sessions of supramaximal HIT (20-min session with 10 × 6-s intervals) or moderate-intensity training (MIT, 40-min session with 3 × 8-min intervals). The primary aim was outcomes on applicability regarding; adherence to prescribed external interval intensity, participant reported positive and negative events, ratings of perceived exertion (RPE 6–20), and affective state (Feeling Scale, FS -5–5). A secondary aim was to investigate change in exercise-related self-efficacy (Exercise Self-Efficacy Scale) and motivation (Behavioural Regulations in Exercise Questionnaire-2). Total adherence to the prescribed external interval intensity was [median (min; max)] 89 % (56; 100 %) in supramaximal HIT, and 100 % (95; 100 %) in MIT. The supramaximal HIT group reported 60 % of the positive (112 of 186) and 36 % of the negative (52 of 146) events. At the end of the training period, the median (min; max) session RPE was 15 (12; 17) for supramaximal HIT and 14 (9; 15) for MIT. As for FS, the median last within-session rating was 3 (−1; 5) for supramaximal HIT and 3 (1; 5) for MIT. Exercise-related motivation increased (mean difference in Relative Autonomy Index score = 1.54, 95 % CI [0.69; 2.40]), while self-efficacy did not change (mean difference = 0.55, 95 % CI [-0.75; 1.82]), regardless of group. This study provide support for supramaximal HIT in supervised group settings for older adults.
  •  
14.
  •  
15.
  • Hallqvist, Andreas, 1973, et al. (författare)
  • Dose escalation to 84 Gy with concurrent chemotherapy in stage III NSCLC appears excessively toxic: Results from a prematurely terminated randomized phase II trial
  • 2018
  • Ingår i: Lung Cancer. - : Elsevier BV. - 0169-5002 .- 1872-8332. ; 122, s. 180-186
  • Tidskriftsartikel (refereegranskat)abstract
    • Objectives: Concurrent chemoradiotherapy is the mainstay treatment for NSCLC stage III disease. To investigate whether radiation dose escalation based on individual normal tissue constraints can improve outcome, the Swedish lung cancer study group launched this randomized phase II trial. Materials and Methods: NSCLC patients with stage III disease, good performance status (0-1) and adequate lung function (FEV1 > 1.0 L and CO diffusion capacity > 40%) received three cycles of cisplatin (75 mg/m(2) day 1) and vinorelbine (25 mg/m(2) day 1 and 8) every third week. Radiotherapy started concurrently with the second cycle, with either 2 Gy daily, 5 days a week, to 68 Gy (A) or escalated therapy (B) based on constraints to the spinal cord, esophagus and lungs up to 84 Gy by adding an extra fraction of 2 Gy per week. Results: A pre-planned safety analysis revealed excessive toxicity and decreased survival in the escalated arm, and the study was stopped. Thirty-six patients were included during 2011-2013 (56% male, 78% with adenocarcinoma, 64% with PS 0 and 53% with stage IIIB). The median progression-free survival (PFS) and overall survival (OS) were 11 and 17 months in arm B compared to the encouraging results of 28 and 45 months in the standard arm. The 1- and 3-year survival rates were 56% and 33% (B) and 72% and 56% (A), respectively. There were seven toxicity-related deaths due to esophageal perforations and pneumonitis: five in the escalated group and two with standard treatment. Conclusion: Dose-escalated concurrent chemoradiotherapy to 84 Gy to primary tumor and nodal disease is hazardous, with a high risk of excessive toxicity, whereas modern standard dose chemoradiotherapy with proper staging given in the control arm shows a promising outcome with a median survival of 45 months and a 3-year survival of 56% (NCT01664663).
  •  
16.
  •  
17.
  •  
18.
  • Holmberg, Erik, 1951, et al. (författare)
  • Dose-response relationship for parathyroid adenoma after exposure to ionizing radiation in infancy.
  • 2002
  • Ingår i: Radiation research. - 0033-7587. ; 158:4, s. 418-23
  • Tidskriftsartikel (refereegranskat)abstract
    • Several authors have suggested that there is an excess risk of hyperparathyroidism, adenomas or hyperplasia after exposure to ionizing radiation. There is still, however, some uncertainty about this association, because these diseases are often asymptomatic and escape clinical detection if not specially searched for. This study is based on a pooled Swedish cohort of 27,925 persons with skin hemangiomas. The majority received radiation treatment in infancy between 1920 and 1965 in Stockholm and Gothenburg. The mean age at treatment was 6 months and the median thyroid dose was 0.20 Gy (range 0-28.5 Gy). Record linkage with the Swedish Cancer Register for the period 1958-1997 gave 43 cases of parathyroid adenoma in the cohort. Analyses of excess relative risk (ERR) models were performed using Poisson regression methods. Clinical records were scrutinized to determine if the childhood radiation exposure was known (biased cases) at the time of diagnosis. Seven of the cases of parathyroid adenoma were classified as biased cases. The standardized incidence ratio (SIR) was 2.10 (95% confidence interval 1.52-2.82) when all cases were included and 1.76 (95% CI 1.23-2.43) with the biased cases excluded. A linear dose-response model with stratification for sex fitted the data best. The ERR per gray was 3.84 (95% CI 1.56-8.99) with all cases and 1.56 (95% CI 0.36-4.45) with the biased cases excluded. There was a significant difference in the ERR per gray between the two subcohorts, probably because of different diagnostic activity in the regions. Our findings confirm that there is a dose-response relationship for radiation-induced parathyroid adenomas.
  •  
19.
  • Holmberg, Erland, et al. (författare)
  • Reaction conditions for the resolution of 2-methylalkanoic acids in esterification and hydrolysis with lipase from Candida cylindracea
  • 1991
  • Ingår i: Applied Microbiology and Biotechnology. - 0175-7598. ; 35:5, s. 572-578
  • Tidskriftsartikel (refereegranskat)abstract
    • We have demonstrated resolution of 2-methylalkanoic acids using lipase from Candida cylindracea as a catalyst. The resolution of 2-methyldecanoic acid was more successful than that of 2-methylbutyric acid both by esterification and hydrolysis. This indicates that the resolution of the acid is dependent on the chain length of the acid moiety. The chain length of the alcohol moiety of the ester affected the resolution of the long-chain acid only. Using esterification, (R)-2-methyldecanoic acid was produced in an enantiomeric excess (e.e.) of 95% (E = 40). If the enantiomeric ratio is low (E = 3.6), as in the resolution of 2-methylbutyric acid, esterification combined with a high equilibrium conversion could be used to yield the remaining acid in a high e.e. In the hydrolytic reactions, the e.e. and the equilibrium conversion were dependent on the pH and the presence of CaCl2. When octyl 2-methyldecanoate was hydrolysed at pH 8.0 in the presence of CaCl2, the (S)-acid was formed with an e.e. of 80% (E = 9), but when the hydrolysis was carried out at pH 7.5 without CaCl2, a very low e.e. and a low equilibrium conversion were observed. The latter conditions allowed the esterification of 2-methyldecanoic acid with 1-octanol even in aqueous medium.
  •  
20.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 11-20 av 467
Typ av publikation
tidskriftsartikel (290)
konferensbidrag (69)
rapport (46)
bokkapitel (34)
doktorsavhandling (10)
annan publikation (7)
visa fler...
bok (3)
forskningsöversikt (3)
samlingsverk (redaktörskap) (2)
licentiatavhandling (2)
konstnärligt arbete (1)
visa färre...
Typ av innehåll
refereegranskat (322)
övrigt vetenskapligt/konstnärligt (131)
populärvet., debatt m.m. (13)
Författare/redaktör
Holmberg, Erik, 1951 (148)
Holmberg, Jan-Erik (48)
Holmberg, Erik (44)
Holmberg, Lars (40)
Karlsson, Per, 1963 (38)
Johansson, Jan-Erik (28)
visa fler...
Holmberg, Claes-Göra ... (26)
Andersson, Erik (23)
Holmberg, Per-Erik (23)
Hugosson, Jonas, 195 ... (21)
Stattin, Pär (19)
Bill-Axelson, Anna (19)
Hedling, Erik (19)
Garmo, Hans (18)
Adami, Hans Olov (16)
Borgfeldt, Christer (16)
Mortensen, Anders (15)
Wahlund, Jan-Erik (15)
Adolfsson, Jan (14)
Holmberg, Hans-Chris ... (14)
Nilsson, Helena (14)
Hedén, Birger (14)
Malmström, Per (13)
Bjurberg, Maria (13)
Stålberg, Karin (13)
Holmberg, Hans-Chris ... (13)
Högberg, Thomas (13)
Steineck, Gunnar, 19 ... (12)
Lundstedt, Dan, 1970 (12)
Dahm-Kähler, Pernill ... (11)
Sjöström, Martin (11)
Knochenhauer, M. (11)
Stranne, Johan, 1970 (10)
Ørtenblad, Niels (10)
Kjölhede, Preben (10)
Rosenberg, Per (10)
Fernö, Mårten (9)
Killander, Fredrika (9)
Åvall-Lundqvist, Eli ... (9)
Rosendahl, Erik (9)
Godtman, Rebecka Arn ... (9)
Tholander, Bengt (9)
Hellman, Kristina (8)
Ljung, Per Erik (8)
Carlsson, Sigrid, 19 ... (8)
Stöggl, Thomas (8)
Rizell, Magnus, 1963 (8)
Marcickiewicz, Janus ... (8)
Lundell, Marie (8)
Stenmark Tullberg, A ... (8)
visa färre...
Lärosäte
Göteborgs universitet (171)
Uppsala universitet (118)
Lunds universitet (112)
Karolinska Institutet (99)
Kungliga Tekniska Högskolan (60)
Umeå universitet (54)
visa fler...
Linköpings universitet (51)
Mittuniversitetet (34)
RISE (27)
Örebro universitet (20)
Chalmers tekniska högskola (14)
Luleå tekniska universitet (13)
Mälardalens universitet (7)
Stockholms universitet (3)
Linnéuniversitetet (3)
VTI - Statens väg- och transportforskningsinstitut (3)
Högskolan i Gävle (2)
Naturvårdsverket (1)
Högskolan i Skövde (1)
Karlstads universitet (1)
Försvarshögskolan (1)
Högskolan Dalarna (1)
Marie Cederschiöld högskola (1)
visa färre...
Språk
Engelska (395)
Svenska (64)
Odefinierat språk (3)
Latin (2)
Tyska (1)
Norska (1)
visa fler...
Finska (1)
visa färre...
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (249)
Humaniora (86)
Naturvetenskap (45)
Teknik (27)
Samhällsvetenskap (19)
Lantbruksvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy